Immunocore Holdings plc ADR [IMCR] stock prices are up 4.45% to $36.60 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IMCR shares have gain 17.27% over the last week, with a monthly amount glided 21.59%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Immunocore Holdings plc ADR [NASDAQ: IMCR] stock has seen the most recent analyst activity on May 27, 2025, when Deutsche Bank initiated its Buy rating and assigned the stock a price target of $65. Previously, Morgan Stanley downgraded its rating to Equal-Weight on December 13, 2024, and dropped its price target to $35. On November 11, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $38 on the stock. UBS started tracking the stock assigning a Sell rating and suggested a price target of $24 on October 24, 2024. Guggenheim downgraded its rating to a Neutral. Leerink Partners started tracking with a Outperform rating for this stock on April 29, 2024, and assigned it a price target of $74.
The stock price of Immunocore Holdings plc ADR [IMCR] has been fluctuating between $23.15 and $49.05 over the past year. Currently, Wall Street analysts expect the stock to reach $35 within the next 12 months. Immunocore Holdings plc ADR [NASDAQ: IMCR] shares were valued at $36.60 at the most recent close of the market. An investor can expect a potential drop of -4.37% based on the average IMCR price forecast.
Analyzing the IMCR fundamentals
The Immunocore Holdings plc ADR [NASDAQ:IMCR] reported sales of 334.07M for trailing twelve months, representing a surge of 33.75%. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -0.14%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.06 and Total Capital is -0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 34.98 points at the first support level, and at 33.35 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.60, and for the 2nd resistance point, it is at 38.59.
Ratios To Look Out For
It’s worth pointing out that Immunocore Holdings plc ADR [NASDAQ:IMCR]’s Current Ratio is 6.36. In addition, the Quick Ratio stands at 6.31 and the Cash Ratio stands at 3.2. Considering the valuation of this stock, the price to sales ratio is 5.50, the price to book ratio is 4.88.
Transactions by insiders
Recent insider trading involved BAKER BROS. ADVISORS LP, Director, that happened on Mar 17 ’25 when 0.81 million shares were purchased. affiliate, Brian Di Donato completed a deal on Mar 17 ’25 to buy 100000.0 shares. Meanwhile, affiliate Brian Di Donato bought 56250.0 shares on Mar 14 ’25.
